Abstract
Results from the phase II/III PROSPECT trial show that neoadjuvant chemotherapy works just as well as pelvic radiation for patients with locally advanced rectal cancer. Five-year disease-free survival, overall survival, and recurrence rates were almost identical for the two approaches.
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.